Risk assessment and pharmacogenetics in molecular and genomic epidemiology.

Abstract excerpt

In this article, we reviewed the literature on risk assessment (RA) models with and without molecular genomic markers and the current utility of the markers in the pharmacogenetic field. Epidemiological risk assessment is applied using statistical models and equations established from current scientific knowledge of risk and disease. Several papers have reported that traditional RA tools have significant...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Genetic Markers
• Share to Genetic Testing
• Share to Genome, Human